Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LimeWire (LMWR) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

LimeWire vs Enzyme — how do they compare? LimeWire trades at Rp239.93 (market cap Rp123,3M, Rp16,65M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: LimeWire and Enzyme are close in size by market cap, and LimeWire's supply is capped (510,6M / 633M LMWR (81%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold LimeWire for 13 Days and Enzyme for 29 Days on average.

LMWRMLN
Market Cap
Rp123,3MRp134,13M
Volume (24h)
Rp16,65MRp104,56M
Circulating Supply
510,6M / 633M LMWR (81%)3,3M MLN
Typical Hold Time
13 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

LimeWire

LimeWire (LMWR) is trading at Rp234.29 with a market cap of Rp119.94 million, showing a bullish technical signal supported by moving averages. The token is near the pivot point of Rp232, with immediate resistance at Rp238. Current indicators suggest strong trend momentum with ADX readings above 70, while RSI levels remain neutral. No major protocol updates or ecosystem developments have been reported recently.

Overall outlook is cautiously optimistic due to bullish technicals, but limited by neutral oscillators and thin liquidity. Key opportunities include breakout potential above Rp238, while major risks involve low market cap volatility and absence of recent fundamental catalysts. Investors should monitor volume for confirmation of trend strength.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LMWR
64% Buy36% Sell
Avg holding period · 13 Days
MLN

No sentiment data available yet.

About LimeWire

LimeWire is an AI-powered content platform that revives the iconic peer-to-peer brand from the 2000s. Relaunched in 2022, it reshapes how people share, create, and collaborate with the power of AI. At the center of its ecosystem is the LimeWire Token (LMWR), which functions as a payment and reward method and also powers Blocknode, LimeWire’s decentralized GPU infrastructure (DePIN) marketplace.

Read more on LMWR

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN